Quanta Pharma DHB is a pharmaceutical-grade dihydroboldenone preparation at 100mg/ml. DHB is the reduced form of boldenone, no aromatisation, dense dry tissue, strong strength gains, and a well-earned reputation for post-injection discomfort. UK dispatch, tracked delivery.
Quanta Pharma DHB Specifications
DHB (Dihydroboldenone) 100mg/ml by Quanta PharmaQuanta Pharma DHB Research Areas
- Dense lean tissue: Users consistently rate the tissue quality as unusually good
- No oestrogen management: Does not aromatise, so no aromatase inhibitor is required for the compound itself
- Strength: Strong strength gains relative to the water-free presentation
- Injection discomfort: The defining practical drawback, severe enough that people abandon it despite rating the results
How DHB Works
DHB is the reduced form of boldenone in the same way DHT is the reduced form of testosterone. That reduction removes aromatisation entirely, so there is no oestrogen conversion and no water retention.
Its androgenic character means the usual DHT-derivative considerations apply to hair and skin, and it suppresses natural production fully.
DHB vs Masteron
Both are non-aromatising injectables chosen for dry, hard tissue. Masteron is a finishing compound with a modest contribution and no injection-pain reputation. DHB contributes considerably more tissue, and hurts.
If injection discomfort is already a problem for you, masteron is the sane choice.
Read Before You Buy
Why Choose Quanta Pharma DHB?
Pharmaceutical-grade preparation with consistent concentration and a traceable brand. Dispatched from the UK with tracked delivery.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
For use by qualified research personnel only
Keep detailed records of usage and storage as per UK research regulations
Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by trained professionals.
